Dallas, TX, United States of America

Luis F Parada

USPTO Granted Patents = 4 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Dallas, TX (US) (2000 - 2008)
  • New York, NY (US) (2018 - 2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Luis F Parada

Introduction

Luis F Parada is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 4 patents, Parada's work focuses on developing compounds that can effectively target cancer cells.

Latest Patents

Among his latest patents, Parada has developed benzamide or benzamine compounds that are useful as anticancer agents for the treatment of human cancers. These inventions provide small molecule anti-cancer compounds designed for treating tumors that respond to cholesterol biosynthesis inhibition. The compounds selectively inhibit the cholesterol biosynthetic pathway in tumor-derived cancer cells, while sparing normally dividing cells. This targeted approach represents a promising advancement in cancer therapy.

Career Highlights

Luis F Parada is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Parada has collaborated with esteemed colleagues such as Jef K DeBrabander and Kristine S Vogel, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Luis F Parada's innovative contributions to cancer treatment exemplify the potential of targeted therapies in modern medicine. His work not only advances scientific knowledge but also holds promise for improving patient care in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…